Autopsy report · NCT00406744

Efficacy of Retreatments With Intravitreal Bevacizumab

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Poor accrual”

The sponsor’s own words in the registry.

Life of this trial

Registered 6 months after it had already started.
Ran for about 6 months before it stopped.
20 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 3
Sponsor: Asociación para Evitar la Ceguera en México
Sponsor type: University, hospital or other
Conditions: Age Related Macular Degeneration; Choroidal Neovascularization
Interventions: Intravitreal injection of Bevacizumab
Participants: 20
Sites: 1
Countries: Mexico

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.